Clinical Trial Update: Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161) [Phase 3]

View source ↗

Summary

A Phase 3 dose-ranging trial of mometasone furoate nasal spray in children aged 6-11 with seasonal allergic rhinitis has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Mometasone furoate nasal spray (mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Rhinitis, Allergic, Seasonal | Phase 3 | Status: COMPLETED | Results posted: 2019-08-12